Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme

Maianti, J; Tan, G.; Vetere, A.; Welsh, A.; Wagner, B.; Seeliger, M.; Liu, D.

doi:10.1038/s41589-019-0271-0

Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme

Journal Article · Tue Dec 31 23:00:00 EST 2019 · Nature Chemical Biology

DOI:https://doi.org/10.1038/s41589-019-0271-0· OSTI ID:1689863

Maianti, J; Tan, G.; Vetere, A.; Welsh, A.; Wagner, B.; Seeliger, M.; Liu, D.

Research Organization:: Brookhaven National Laboratory (BNL), Upton, NY (United States)

Sponsoring Organization:: ~OTHER

DOE Contract Number:: SC0012704

OSTI ID:: 1689863

Report Number(s):: BNL-220194-2020-JACI

Journal Information:: Nature Chemical Biology, Journal Name: Nature Chemical Biology Vol. 15; ISSN 1552-4450

Country of Publication:: United States

Language:: English

References (56)

(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2 Duggan, Kelsey C.; Hermanson, Daniel J.; Musee, Joel Nature Chemical Biology, Vol. 7, Issue 11 https://doi.org/10.1038/nchembio.663	journal	September 2011
Enhanced Protein C Activation and Inhibition of Fibrinogen Cleavage by a Thrombin Modulator Berg, David T.; Wiley, Michael R.; Grinnell, Brian W. Science, Vol. 273, Issue 5280 https://doi.org/10.1126/science.273.5280.1389	journal	September 1996
Structure–activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzyme Charton, Julie; Gauriot, Marion; Totobenazara, Jane European Journal of Medicinal Chemistry, Vol. 90 https://doi.org/10.1016/j.ejmech.2014.12.005	journal	January 2015
Novel Noncatalytic Substrate-Selective p38α-Specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-Inflammatory Activity Shah, Nirav G.; Tulapurkar, Mohan E.; Ramarathnam, Aparna The Journal of Immunology, Vol. 198, Issue 8 https://doi.org/10.4049/jimmunol.1602059	journal	March 2017
Systematic discovery of linear binding motifs targeting an ancient protein interaction surface on MAP kinases Zeke, András; Bastys, Tomas; Alexa, Anita Molecular Systems Biology, Vol. 11, Issue 11 https://doi.org/10.15252/msb.20156269	journal	November 2015
Guidelines for accurate EC50/IC50 estimation Sebaugh, J. L. Pharmaceutical Statistics, Vol. 10, Issue 2 https://doi.org/10.1002/pst.426	journal	March 2011
Insulin-degrading enzyme regulates the levels of insulin, amyloid -protein, and the -amyloid precursor protein intracellular domain in vivo Farris, W.; Mansourian, S.; Chang, Y. Proceedings of the National Academy of Sciences, Vol. 100, Issue 7 https://doi.org/10.1073/pnas.0230450100	journal	March 2003
Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus Tang, Wei-Jen Trends in Endocrinology & Metabolism, Vol. 27, Issue 1 https://doi.org/10.1016/j.tem.2015.11.003	journal	January 2016
Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis Charton, Julie; Gauriot, Marion; Guo, Qing European Journal of Medicinal Chemistry, Vol. 79 https://doi.org/10.1016/j.ejmech.2014.04.009	journal	May 2014
Data processing and analysis with the autoPROC toolbox Vonrhein, Clemens; Flensburg, Claus; Keller, Peter Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4 https://doi.org/10.1107/S0907444911007773	journal	March 2011
PHENIX: a comprehensive Python-based system for macromolecular structure solution Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221 https://doi.org/10.1107/S0907444909052925	journal	January 2010
Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover Unger, Roger H.; Cherrington, Alan D. Journal of Clinical Investigation, Vol. 122, Issue 1 https://doi.org/10.1172/JCI60016	journal	January 2012
A Monomeric Variant of Insulin Degrading Enzyme (IDE) Loses Its Regulatory Properties Song, Eun Suk; Rodgers, David W.; Hersh, Louis B. PLoS ONE, Vol. 5, Issue 3 https://doi.org/10.1371/journal.pone.0009719	journal	March 2010
Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances: Neprilysin inhibition to treat heart failure McMurray, John J. V. European Journal of Heart Failure, Vol. 17, Issue 3 https://doi.org/10.1002/ejhf.250	journal	March 2015
Optimization of Peptide Hydroxamate Inhibitors of Insulin-Degrading Enzyme Reveals Marked Substrate-Selectivity Abdul-Hay, Samer O.; Lane, Amy L.; Caulfield, Thomas R. Journal of Medicinal Chemistry, Vol. 56, Issue 6 https://doi.org/10.1021/jm301280p	journal	March 2013
Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin Leissring, Malcolm A.; Malito, Enrico; Hedouin, Sabrine PLoS ONE, Vol. 5, Issue 5 https://doi.org/10.1371/journal.pone.0010504	journal	May 2010
Phaser crystallographic software McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D. Journal of Applied Crystallography, Vol. 40, Issue 4 https://doi.org/10.1107/S0021889807021206	journal	July 2007
SHELXT – Integrated space-group and crystal-structure determination Sheldrick, George M. Acta Crystallographica Section A Foundations and Advances, Vol. 71, Issue 1, p. 3-8 https://doi.org/10.1107/S2053273314026370	journal	January 2015
Enzyme target to latch on to Leissring, Malcolm A.; Selkoe, Dennis J. Nature, Vol. 443, Issue 7113 https://doi.org/10.1038/nature05210	journal	October 2006
USER fusion: a rapid and efficient method for simultaneous fusion and cloning of multiple PCR products Geu-Flores, F.; Nour-Eldin, H. H.; Nielsen, M. T. Nucleic Acids Research, Vol. 35, Issue 7 https://doi.org/10.1093/nar/gkm106	journal	March 2007
Tanshinones that selectively block the collagenase activity of cathepsin K provide a novel class of ectosteric antiresorptive agents for bone: Ectosteric inhibitors of cathepsin K Panwar, Preety; Law, Simon; Jamroz, Andrew British Journal of Pharmacology, Vol. 175, Issue 6 https://doi.org/10.1111/bph.14133	journal	February 2018
Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate Madoux, Franck; Dreymuller, Daniela; Pettiloud, Jean-Phillipe Scientific Reports, Vol. 6, Issue 1 https://doi.org/10.1038/s41598-016-0013-4	journal	December 2016
Structure of Substrate-free Human Insulin-degrading Enzyme (IDE) and Biophysical Analysis of ATP-induced Conformational Switch of IDE Im, Hookang; Manolopoulou, Marika; Malito, Enrico Journal of Biological Chemistry, Vol. 282, Issue 35 https://doi.org/10.1074/jbc.M701590200	journal	July 2007
Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice Villa-Pérez, Pablo; Merino, Beatriz; Fernández-Díaz, Cristina M. Metabolism, Vol. 88 https://doi.org/10.1016/j.metabol.2018.08.001	journal	November 2018
Methyl Effects on Protein–Ligand Binding Leung, Cheryl S.; Leung, Siegfried S. F.; Tirado-Rives, Julian Journal of Medicinal Chemistry, Vol. 55, Issue 9 https://doi.org/10.1021/jm3003697	journal	April 2012
OLEX2 : a complete structure solution, refinement and analysis program Dolomanov, Oleg V.; Bourhis, Luc J.; Gildea, Richard J. Journal of Applied Crystallography, Vol. 42, Issue 2 https://doi.org/10.1107/S0021889808042726	journal	January 2009
Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones Maianti, Juan Pablo; McFedries, Amanda; Foda, Zachariah H. Nature, Vol. 511, Issue 7507 https://doi.org/10.1038/nature13297	journal	May 2014
Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo Durham, Timothy B.; Toth, James L.; Klimkowski, Valentine J. Journal of Biological Chemistry, Vol. 290, Issue 33 https://doi.org/10.1074/jbc.M115.638205	journal	June 2015
Two additive mechanisms impair the differentiation of 'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitro Hendriks, Bart S.; Seidl, Kelly M.; Chabot, Jeffrey R. BMC Systems Biology, Vol. 4, Issue 1 https://doi.org/10.1186/1752-0509-4-23	journal	March 2010
Inhibition of MMP-2 gelatinolysis by targeting exodomain–substrate interactions Xu, Xiaoping; Chen, Zhihua; Wang, Yao Biochemical Journal, Vol. 406, Issue 1 https://doi.org/10.1042/BJ20070591	journal	July 2007
Selective Targeting of Extracellular Insulin-Degrading Enzyme by Quasi-Irreversible Thiol-Modifying Inhibitors Abdul-Hay, Samer O.; Bannister, Thomas D.; Wang, Hui ACS Chemical Biology, Vol. 10, Issue 12 https://doi.org/10.1021/acschembio.5b00334	journal	September 2015
Insulin proteinase liberates from glucagon a fragment known to have enhanced activity against Ca2+ + Mg2+-dependent ATPase Rose, K.; Savoy, L. A.; Muir, A. V. Biochemical Journal, Vol. 256, Issue 3 https://doi.org/10.1042/bj2560847	journal	December 1988
Insulin and Glucagon Degradation by the Same Enzyme Duckworth, William C.; Kitabchi, Abbas E. Diabetes, Vol. 23, Issue 6 https://doi.org/10.2337/diab.23.6.536	journal	June 1974
Emerging principles in protease-based drug discovery Drag, Marcin; Salvesen, Guy S. Nature Reviews Drug Discovery, Vol. 9, Issue 9 https://doi.org/10.1038/nrd3053	journal	September 2010
SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A D isintegrin A nd M etalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes Knapinska, Anna M.; Dreymuller, Daniela; Ludwig, Andreas Journal of Medicinal Chemistry, Vol. 58, Issue 15 https://doi.org/10.1021/acs.jmedchem.5b00354	journal	August 2015
Coot model-building tools for molecular graphics Emsley, Paul; Cowtan, Kevin Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132 https://doi.org/10.1107/S0907444904019158	journal	November 2004
Substrate Activation of Insulin-degrading Enzyme (Insulysin): A POTENTIAL TARGET FOR DRUG DEVELOPMENT Song, Eun-Suk; Juliano, Maria Aparecida; Juliano, Luiz Journal of Biological Chemistry, Vol. 278, Issue 50 https://doi.org/10.1074/jbc.M308983200	journal	October 2003
Comparison of silver and molybdenum microfocus X-ray sources for single-crystal structure determination Krause, Lennard; Herbst-Irmer, Regine; Sheldrick, George M. Journal of Applied Crystallography, Vol. 48, Issue 1 https://doi.org/10.1107/S1600576714022985	journal	January 2015
A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1 Rettenmaier, T. Justin; Sadowsky, Jack D.; Thomsen, Nathan D. Proceedings of the National Academy of Sciences, Vol. 111, Issue 52 https://doi.org/10.1073/pnas.1415365112	journal	December 2014
Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice Deprez-Poulain, Rebecca; Hennuyer, Nathalie; Bosc, Damien Nature Communications, Vol. 6, Issue 1 https://doi.org/10.1038/ncomms9250	journal	September 2015
Crystal structure refinement with SHELXL Sheldrick, George M. Acta Crystallographica Section C Structural Chemistry, Vol. 71, Issue 1, p. 3-8 https://doi.org/10.1107/S2053229614024218	journal	January 2015
Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes Ahren, Bo Vascular Health and Risk Management https://doi.org/10.2147/VHRM.S33934	journal	April 2013
Fluorescence polarization assays in high-throughput screening and drug discovery: a review Hall, Matthew D.; Yasgar, Adam; Peryea, Tyler Methods and Applications in Fluorescence, Vol. 4, Issue 2 https://doi.org/10.1088/2050-6120/4/2/022001	journal	April 2016
Purification and characterization of a rat liver cytosol neutral thiol peptidase that degrades glucagon, insulin, and isolated insulin A and B chains Shroyer, Lois A.; Varandani, Partab T. Archives of Biochemistry and Biophysics, Vol. 236, Issue 1 https://doi.org/10.1016/0003-9861(85)90620-4	journal	January 1985
Insulin-Degrading Enzyme Inhibition, a Novel Therapy for Type 2 Diabetes? Costes, Safia; Butler, Peter C. Cell Metabolism, Vol. 20, Issue 2 https://doi.org/10.1016/j.cmet.2014.07.016	journal	August 2014
Deletion of Insulin-Degrading Enzyme Elicits Antipodal, Age-Dependent Effects on Glucose and Insulin Tolerance Abdul-Hay, Samer O.; Kang, Dongcheul; McBride, Melinda PLoS ONE, Vol. 6, Issue 6 https://doi.org/10.1371/journal.pone.0020818	journal	June 2011
Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism Shen, Yuequan; Joachimiak, Andrzej; Rich Rosner, Marsha Nature, Vol. 443, Issue 7113 https://doi.org/10.1038/nature05143	journal	October 2006
Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme McCord, Lauren A.; Liang, Wenguang G.; Dowdell, Evan Proceedings of the National Academy of Sciences, Vol. 110, Issue 34 https://doi.org/10.1073/pnas.1304575110	journal	August 2013
Substrate-Selective Inhibition of Protein Kinase PDK1 by Small Compounds that Bind to the PIF-Pocket Allosteric Docking Site Busschots, Katrien; Lopez-Garcia, Laura A.; Lammi, Carmen Chemistry & Biology, Vol. 19, Issue 9 https://doi.org/10.1016/j.chembiol.2012.07.017	journal	September 2012
Amyloid β-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin Malito, E.; Hulse, R. E.; Tang, W. -J. Cellular and Molecular Life Sciences, Vol. 65, Issue 16 https://doi.org/10.1007/s00018-008-8112-4	journal	May 2008
Synthesis and Profiling of a Diverse Collection of Azetidine-Based Scaffolds for the Development of CNS-Focused Lead-like Libraries Lowe, Jason T.; Lee, Maurice D.; Akella, Lakshmi B. The Journal of Organic Chemistry, Vol. 77, Issue 17 https://doi.org/10.1021/jo300974j	journal	August 2012
Is there new hope for therapeutic matrix metalloproteinase inhibition? Vandenbroucke, Roosmarijn E.; Libert, Claude Nature Reviews Drug Discovery, Vol. 13, Issue 12 https://doi.org/10.1038/nrd4390	journal	November 2014
The Type 2 Diabetes-Associated Gene Ide Is Required for Insulin Secretion and Suppression of -Synuclein Levels in -Cells Steneberg, P.; Bernardo, L.; Edfalk, S. Diabetes, Vol. 62, Issue 6 https://doi.org/10.2337/db12-1045	journal	January 2013
Degradation of Amylin by Insulin-degrading Enzyme Bennett, Robert G.; Duckworth, William C.; Hamel, Frederick G. Journal of Biological Chemistry, Vol. 275, Issue 47 https://doi.org/10.1074/jbc.M006170200	journal	November 2000
HTRF: A Technology Tailored for Drug Discovery - A Review of Theoretical Aspects and Recent Applications Degorce, Francois Current Chemical Genomics, Vol. 3, Issue 1 https://doi.org/10.2174/1875397300903010022	journal	March 2009
Molecular Bases for the Recognition of Short Peptide Substrates and Cysteine-Directed Modifications of Human Insulin-Degrading Enzyme ^† Malito, Enrico; Ralat, Luis A.; Manolopoulou, Marika Biochemistry, Vol. 47, Issue 48 https://doi.org/10.1021/bi801192h	journal	December 2008

Similar Records

Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin

Journal Article · Mon Sep 20 00:00:00 EDT 2010 · PLoS One · OSTI ID:1002705

Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin

Journal Article · Tue Sep 17 00:00:00 EDT 2013 · PLoS One · OSTI ID:1023638

Anti-diabetic Activity of Insulin-degrading Enzyme Inhibitors Mediated by Multiple Hormones

Journal Article · Thu Jul 03 00:00:00 EDT 2014 · Nature · OSTI ID:1162444

Related Subjects

99 GENERAL AND MISCELLANEOUS

Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme

Citation Formats

References (56)

Similar Records

Related Subjects